Dr. Boyle’s biotech and intellectual property expertise strengthen the team as the company proceeds to next phase of its HIV cure clinical trial American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post with deep biotechnology expertise which will help further accelerate the… [Read More]
American Gene Technologies says clinical trial shows increases in immunity against HIV
Original post on ABC7 News ROCKVILLE, Md. (7News) — There’s more good news in the fight to cure HIV. American Gene Technologies says its clinical trial has resulted in more patients with substantial increases in virus-specific T-cells with immunity against HIV. Progress in HIV cure: AGT hopes to have a ‘functionally cured patient… [Read More]
Gene Therapy: Jeff Galvin’s Big Idea That Might Change The World
Original Post on medium.com Don’t mistake “wants” for “needs” in your life. We hardly need anything to survive, and if we don’t get caught up on the materialistic world that media, corporations, and politicians sell us in order to perpetuate their agendas, it leaves us free to pursue our passions. Passion is the “secret sauce”… [Read More]
Why Focus on Treating Diseases Instead of Curing Them?
Original Post on lifescivoice.com and written by: Jeff Galvin It’s a tragic irony: So much money has been poured into treating diseases, but far less into actually curing them. The pharmaceutical industry has done an incredible job of developing highly profitable treatments for a wide range of diseases and conditions. Those treatments have generated trillions… [Read More]
American Gene Technologies Attracts Investment from Ride Wave Ventures
AGT welcomes additional support of its HIV Cure clinical trial and broad gene therapy development platform American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, announced today that angel investor Ride Wave Ventures has made its first investment in the company. Ride Wave Ventures’ investment adds to the more than $50 million… [Read More]
American Gene Technologies Launches “The Cure Chronicles” Video Series
“The Cure Chronicles” presents thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working toward ending the HIV epidemic. American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, has launched a video series showcasing compelling HIV community conversations: The Cure Chronicles, hosted by the company’s CEO Jeff Galvin. … [Read More]
American Gene Technologies Applauds the State of Maryland for Supporting Biotech Investment
Maryland’s Biotechnology Investment Incentive Tax Credit (BIITC) program generates multiple benefits for the state American Gene Technologies (AGT), a clinical-stage biotechnology company working to cure HIV, thanks the State of Maryland for its commitment to supporting biotech research through initiatives like the Biotechnology Investment Incentive Tax Credit (BIITC) program. While AGT is no longer eligible… [Read More]
American Gene Technologies Advances Closer to Demonstrating a Potential Cure for HIV
HIV cure clinical trial data shows safety and efficacy of AGT’s gene therapy treatment, the company will begin withdrawing participants from antiretrovirals in Q2 to test potential functional cure American Gene Technologies (AGT), a clinical-stage biotechnology company working to cure HIV, announced that the independent Institutional Review Board (IRB) overseeing its clinical trial approved the… [Read More]
American Gene Technologies’ HIV Clinical Trial Shows Blood Markers of Efficacy in Two More Patients
Data from a Total of Five Patients Demonstrates Critical Markers of the Company’s HIV Cure Gene & Cell Therapy American Gene Technologies (AGT), a clinical-stage biotechnology company working to cure HIV, announced that it has reached another important milestone for its HIV cure program. Five participants were treated with AGT103-T and are stably engrafted with genetically… [Read More]
Is There a Cure for HIV?
The Food and Drug Administration (FDA) recently approved the first injectable treatment for HIV pre-exposure prophylaxis (PrEP), which is critically important to prevent the spread of HIV, considering around 1.5 million people were newly infected with the disease in 2020. But ultimately, to end this epidemic and stop the suffering of nearly 38 million people… [Read More]
American Gene Technologies Appoints Dr. Drew Palin as Business and Strategy Advisor to the CEO
Dr. Palin’s expertise in the intersection of business and technology strengthens AGT’s capability to bring patient solutions to the market. American Gene Technologies (AGT) announces the appointment of Dr. Drew Palin as business and strategy advisor to Jeff Galvin, CEO. “I am excited to have Drew officially on board. He has been informally advising me… [Read More]
American Gene Technologies’ HIV Clinical Trial Demonstrates Blood Markers of Efficacy
Data from the First Three Patients Shows Critical Markers of the HIV Cure Cell Therapy: Engraftment, Persistence, and Function of Infused Cells American Gene Technologies (AGT), a clinical-stage biotechnology company working to cure HIV, announced that it has reached two important milestones for its HIV cure program. All three patients achieved engraftment of the genetically… [Read More]
